コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 or the effects on recurrent VTE and abnormal uterine bleeding.
2 , to either abate or mitigate the effects of uterine bleeding.
3 ve endometrial sampling only in the event of uterine bleeding.
4 tion with placenta previa but not with other uterine bleeding.
5 venous malformation (AVM) is a rare cause of uterine bleeding.
6 e evaluation and treatment of mild-to-severe uterine bleeding.
7 d women with symptomatic fibroids, excessive uterine bleeding (a score of >100 on the pictorial blood
8 edical conditions from endometrial cancer to uterine bleeding and as an important component of oral c
10 ce-monthly leuprolide acetate in controlling uterine bleeding and were significantly less likely to c
16 smoking was not found to be associated with uterine bleeding of unknown etiology (relative risk = 1.
18 1,000 pregnancies, while placenta previa and uterine bleeding of unknown etiology were indicated in 3
19 or placental abruption, placenta previa, and uterine bleeding of unknown origin suggests that these t
21 oprimary efficacy end points were control of uterine bleeding (PBAC score of <75) and reduction of fi
22 tumors of the myometrium and cause irregular uterine bleeding, severe anemia, and recurrent pregnancy
23 ents with symptomatic fibroids and excessive uterine bleeding to receive 3 months of daily therapy wi
24 roscopy was estimated in women with abnormal uterine bleeding, using histopathologic findings as a re
27 it frequently causes episodes of unscheduled uterine bleeding, which could be associated with prolife
28 the incidences of recurrent VTE and abnormal uterine bleeding with and without concomitant hormonal t
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。